小児用ワクチンの世界市場

◆英語タイトル:Pediatric Vaccines - Global Market Outlook (2015-2022)
◆商品コード:SMRC65156
◆発行会社(調査会社):Stratistics MRC
◆発行日:2016年3月
◆ページ数:145
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD4,150 ⇒換算¥468,950見積依頼/購入/質問フォーム
2-5 UserUSD5,250 ⇒換算¥593,250見積依頼/購入/質問フォーム
Global Site LicenseUSD7,500 ⇒換算¥847,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はStratistics MRC社の日本における正規販売代理店です。Stratistics MRC社の概要及び新刊レポートはこちらでご確認いただけます。
当調査レポートでは、小児用ワクチンの世界市場について調査・分析し、市場動向、市場規模、市場予測、企業動向などを含め、以下の構成でお届けいたします。

・エグゼクティブサマリー
・序文
・市場動向分析
・ファイブフォース分析(市場環境分析)
・小児用ワクチンの世界市場:疾患種類別分析/市場規模
・小児用ワクチンの世界市場:製品種類別分析/市場規模
・小児用ワクチンの世界市場:ワクチン別分析/市場規模
・小児用ワクチンの世界市場:地域別分析/市場規模
・小児用ワクチンのアメリカ市場規模予測
・小児用ワクチンのヨーロッパ市場規模予測
・小児用ワクチンのアジア市場規模予測
・企業動向
・企業分析
【レポートの概要】

According to Stratistics MRC, the Global Pediatric Vaccines market is estimated at $XX million in 2015 and is expected to grow at a CAGR of XX% to reach $XX million by 2022. Rising government and non-government financial support for development of vaccine is the major driver for the pediatric vaccine market. Increasing innovative technologies such as therapeutic and adjuvant vaccines are anticipated to fuel the pediatric vaccine market during the forecast period. Moreover, increasing expenditure of vaccines, little accessibility to remote areas and strict regulation for approval of vaccines are some of the factors hampering the global pediatric vaccine market.
Infectious diseases segment is expected to grow at a faster rate during the forecast period. North America dominates the global market for pediatric vaccines followed by Europe. Moreover, the Asia Pacific is likely to report the highest CAGR during the forecast period, driven by the high birth rate in China and India.

Some of the key players in the market include Johnson and Johnson, Abbott Laboratories, Baxter International, Eli Lilly and Company, Sanofi S.A, Novo Nordisk A/S, Bharat Biotech International Limited, Actelion Pharmaceuticals Ltd, Genentech, Inc., Shire Pharmaceuticals Group Plc, Merck & Co. Inc, Bristol-Myers Squibb Company, Amgen Inc., Novartis AG and Boehringer Ingelheim GmbH.

Diseases type Covered:
• Cancer and allergy
• Infectious disease
o Pneumococcal disease
o Influenza
o Diphtheria
o Rotavirus
o Tetanus
o Haemophilus Influenzae type b (Hib)
o Meningococcal
o Hepatitis A
o Hepatitis B
o Rubella
o Mumps
o Measles
o Pertussis
o Varicella (chickenpox)
o Polio

Products Covered:
• Anti-infective drugs
• Pediatric hormones
• Allergy & respiratory drugs
• CNS drugs

Vaccines type Covered:
• Synthetic vaccines
• Conjugate vaccines
• Live attenuated vaccines
• Dendritic cells vaccines
• Toxoid vaccines
• Recombinant vector vaccines
• Subunit vaccines
• Inactivated vaccines

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o Rest of Asia Pacific
• Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

【レポートの目次】

1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Emerging Markets

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Pediatric Vaccines Market, By Diseases type
5.1 Introduction
5.2 Cancer and allergy
5.3 Infectious disease
5.3.1 Pneumococcal disease
5.3.2 Influenza
5.3.3 Diphtheria
5.3.4 Rotavirus
5.3.5 Tetanus
5.3.6 Haemophilus Influenzae type b (Hib)
5.3.7 Meningococcal
5.3.8 Hepatitis A
5.3.9 Hepatitis B
5.3.10 Rubella
5.3.11 Mumps
5.3.12 Measles
5.3.13 Pertussis
5.3.14 Varicella (chickenpox)
5.3.15 Polio

6 Global Pediatric Vaccines Market, By Product
6.1 Introduction
6.2 Anti-infective drugs
6.3 Pediatric hormones
6.4 Allergy & respiratory drugs
6.5 CNS drugs

7 Global Pediatric Vaccines Market, By Vaccines type
7.1 Introduction
7.2 Synthetic vaccines
7.3 Conjugate vaccines
7.4 Live attenuated vaccines
7.5 Dendritic cells vaccines
7.6 Toxoid vaccines
7.7 Recombinant vector vaccines
7.8 Subunit vaccines
7.9 Inactivated vaccines

8 Global Pediatric Vaccines Market, By Geography
8.1 North America
8.1.1 US
8.1.2 Canada
8.1.3 Mexico
8.2 Europe
8.2.1 Germany
8.2.2 France
8.2.3 Italy
8.2.4 UK
8.2.5 Spain
8.2.6 Rest of Europe
8.3 Asia Pacific
8.3.1 Japan
8.3.2 China
8.3.3 India
8.3.4 Australia
8.3.5 New Zealand
8.3.6 Rest of Asia Pacific
8.4 Rest of the World
8.4.1 Middle East
8.4.2 Brazil
8.4.3 Argentina
8.4.4 South Africa
8.4.5 Egypt

9 Key Developments
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies

10 Company Profiling
10.1 Johnson and Johnson
10.2 Abbott Laboratories
10.3 Baxter International
10.4 Eli Lilly and Company
10.5 Sanofi S.A
10.6 Novo Nordisk A/S
10.7 Bharat Biotech International Limited
10.8 Actelion Pharmaceuticals Ltd
10.9 Genentech, Inc.
10.10 Shire Pharmaceuticals Group Plc
10.11 Merck & Co. Inc
10.12 Bristol-Myers Squibb Company
10.13 Amgen Inc.
10.14 Novartis AG.
10.15 Boehringer Ingelheim GmbH

List of Tables
Table 1 Global Pediatric Vaccines Market Outlook, By Region (2013-2022) ($MN)
Table 2 Global Pediatric Vaccines Market Outlook, By Diseases type (2013-2022) ($MN)
Table 3 Global Pediatric Vaccines Market Outlook, By Cancer and allergy (2013-2022) ($MN)
Table 4 Global Pediatric Vaccines Market Outlook, By Infectious disease (2013-2022) ($MN)
Table 5 Global Pediatric Vaccines Market Outlook, By Pneumococcal disease (2013-2022) ($MN)
Table 6 Global Pediatric Vaccines Market Outlook, By Influenza (2013-2022) ($MN)
Table 7 Global Pediatric Vaccines Market Outlook, By Diphtheria (2013-2022) ($MN)
Table 8 Global Pediatric Vaccines Market Outlook, By Rotavirus (2013-2022) ($MN)
Table 9 Global Pediatric Vaccines Market Outlook, By Tetanus (2013-2022) ($MN)
Table 10 Global Pediatric Vaccines Market Outlook, By Haemophilus Influenzae type b (Hib) (2013-2022) ($MN)
Table 11 Global Pediatric Vaccines Market Outlook, By Meningococcal (2013-2022) ($MN)
Table 12 Global Pediatric Vaccines Market Outlook, By Hepatitis A (2013-2022) ($MN)
Table 13 Global Pediatric Vaccines Market Outlook, By Hepatitis B (2013-2022) ($MN)
Table 14 Global Pediatric Vaccines Market Outlook, By Rubella (2013-2022) ($MN)
Table 15 Global Pediatric Vaccines Market Outlook, By Mumps (2013-2022) ($MN)
Table 16 Global Pediatric Vaccines Market Outlook, By Measles (2013-2022) ($MN)
Table 17 Global Pediatric Vaccines Market Outlook, By Pertussis (2013-2022) ($MN)
Table 18 Global Pediatric Vaccines Market Outlook, By Varicella (chickenpox) (2013-2022) ($MN)
Table 19 Global Pediatric Vaccines Market Outlook, By Polio (2013-2022) ($MN)
Table 20 Global Pediatric Vaccines Market Outlook, By Product (2013-2022) ($MN)
Table 21 Global Pediatric Vaccines Market Outlook, By Anti-infective drugs (2013-2022) ($MN)
Table 22 Global Pediatric Vaccines Market Outlook, By Pediatric hormones (2013-2022) ($MN)
Table 23 Global Pediatric Vaccines Market Outlook, By Allergy & respiratory drugs (2013-2022) ($MN)
Table 24 Global Pediatric Vaccines Market Outlook, By CNS drugs (2013-2022) ($MN)
Table 25 Global Pediatric Vaccines Market Outlook, By Vaccines type (2013-2022) ($MN)
Table 26 Global Pediatric Vaccines Market Outlook, By Synthetic vaccines (2013-2022) ($MN)
Table 27 Global Pediatric Vaccines Market Outlook, By Conjugate vaccines (2013-2022) ($MN)
Table 28 Global Pediatric Vaccines Market Outlook, By Live attenuated vaccines (2013-2022) ($MN)
Table 29 Global Pediatric Vaccines Market Outlook, By Dendritic cells vaccines (2013-2022) ($MN)
Table 30 Global Pediatric Vaccines Market Outlook, By Toxoid vaccines (2013-2022) ($MN)
Table 31 Global Pediatric Vaccines Market Outlook, By Recombinant vector vaccines (2013-2022) ($MN)
Table 32 Global Pediatric Vaccines Market Outlook, By Subunit vaccines (2013-2022) ($MN)
Table 33 Global Pediatric Vaccines Market Outlook, By Inactivated vaccines (2013-2022) ($MN)
Table 34 North America Pediatric Vaccines Market Outlook, By Diseases type (2013-2022) ($MN)
Table 35 North America Pediatric Vaccines Market Outlook, By Cancer and allergy (2013-2022) ($MN)
Table 36 North America Pediatric Vaccines Market Outlook, By Infectious disease (2013-2022) ($MN)
Table 37 North America Pediatric Vaccines Market Outlook, By Pneumococcal disease (2013-2022) ($MN)
Table 38 North America Pediatric Vaccines Market Outlook, By Influenza (2013-2022) ($MN)
Table 39 North America Pediatric Vaccines Market Outlook, By Diphtheria (2013-2022) ($MN)
Table 40 North America Pediatric Vaccines Market Outlook, By Rotavirus (2013-2022) ($MN)
Table 41 North America Pediatric Vaccines Market Outlook, By Tetanus (2013-2022) ($MN)
Table 42 North America Pediatric Vaccines Market Outlook, By Haemophilus Influenzae type b (Hib) (2013-2022) ($MN)
Table 43 North America Pediatric Vaccines Market Outlook, By Meningococcal (2013-2022) ($MN)
Table 44 North America Pediatric Vaccines Market Outlook, By Hepatitis A (2013-2022) ($MN)
Table 45 North America Pediatric Vaccines Market Outlook, By Hepatitis B (2013-2022) ($MN)
Table 46 North America Pediatric Vaccines Market Outlook, By Rubella (2013-2022) ($MN)
Table 47 North America Pediatric Vaccines Market Outlook, By Mumps (2013-2022) ($MN)
Table 48 North America Pediatric Vaccines Market Outlook, By Measles (2013-2022) ($MN)
Table 49 North America Pediatric Vaccines Market Outlook, By Pertussis (2013-2022) ($MN)
Table 50 North America Pediatric Vaccines Market Outlook, By Varicella (chickenpox) (2013-2022) ($MN)
Table 51 North America Pediatric Vaccines Market Outlook, By Polio (2013-2022) ($MN)
Table 52 North America Pediatric Vaccines Market Outlook, By Product (2013-2022) ($MN)
Table 53 North America Pediatric Vaccines Market Outlook, By Anti-infective drugs (2013-2022) ($MN)
Table 54 North America Pediatric Vaccines Market Outlook, By Pediatric hormones (2013-2022) ($MN)
Table 55 North America Pediatric Vaccines Market Outlook, By Allergy & respiratory drugs (2013-2022) ($MN)
Table 56 North America Pediatric Vaccines Market Outlook, By CNS drugs (2013-2022) ($MN)
Table 57 North America Pediatric Vaccines Market Outlook, By Vaccines type (2013-2022) ($MN)
Table 58 North America Pediatric Vaccines Market Outlook, By Synthetic vaccines (2013-2022) ($MN)
Table 59 North America Pediatric Vaccines Market Outlook, By Conjugate vaccines (2013-2022) ($MN)
Table 60 North America Pediatric Vaccines Market Outlook, By Live attenuated vaccines (2013-2022) ($MN)
Table 61 North America Pediatric Vaccines Market Outlook, By Dendritic cells vaccines (2013-2022) ($MN)
Table 62 North America Pediatric Vaccines Market Outlook, By Toxoid vaccines (2013-2022) ($MN)
Table 63 North America Pediatric Vaccines Market Outlook, By Recombinant vector vaccines (2013-2022) ($MN)
Table 64 North America Pediatric Vaccines Market Outlook, By Subunit vaccines (2013-2022) ($MN)
Table 65 North America Pediatric Vaccines Market Outlook, By Inactivated vaccines (2013-2022) ($MN)
Table 66 Europe Pediatric Vaccines Market Outlook, By Diseases type (2013-2022) ($MN)
Table 67 Europe Pediatric Vaccines Market Outlook, By Cancer and allergy (2013-2022) ($MN)
Table 68 Europe Pediatric Vaccines Market Outlook, By Infectious disease (2013-2022) ($MN)
Table 69 Europe Pediatric Vaccines Market Outlook, By Pneumococcal disease (2013-2022) ($MN)
Table 70 Europe Pediatric Vaccines Market Outlook, By Influenza (2013-2022) ($MN)
Table 71 Europe Pediatric Vaccines Market Outlook, By Diphtheria (2013-2022) ($MN)
Table 72 Europe Pediatric Vaccines Market Outlook, By Rotavirus (2013-2022) ($MN)
Table 73 Europe Pediatric Vaccines Market Outlook, By Tetanus (2013-2022) ($MN)
Table 74 Europe Pediatric Vaccines Market Outlook, By Haemophilus Influenzae type b (Hib) (2013-2022) ($MN)
Table 75 Europe Pediatric Vaccines Market Outlook, By Meningococcal (2013-2022) ($MN)
Table 76 Europe Pediatric Vaccines Market Outlook, By Hepatitis A (2013-2022) ($MN)
Table 77 Europe Pediatric Vaccines Market Outlook, By Hepatitis B (2013-2022) ($MN)
Table 78 Europe Pediatric Vaccines Market Outlook, By Rubella (2013-2022) ($MN)
Table 79 Europe Pediatric Vaccines Market Outlook, By Mumps (2013-2022) ($MN)
Table 80 Europe Pediatric Vaccines Market Outlook, By Measles (2013-2022) ($MN)
Table 81 Europe Pediatric Vaccines Market Outlook, By Pertussis (2013-2022) ($MN)
Table 82 Europe Pediatric Vaccines Market Outlook, By Varicella (chickenpox) (2013-2022) ($MN)
Table 83 Europe Pediatric Vaccines Market Outlook, By Polio (2013-2022) ($MN)
Table 84 Europe Pediatric Vaccines Market Outlook, By Product (2013-2022) ($MN)
Table 85 Europe Pediatric Vaccines Market Outlook, By Anti-infective drugs (2013-2022) ($MN)
Table 86 Europe Pediatric Vaccines Market Outlook, By Pediatric hormones (2013-2022) ($MN)
Table 87 Europe Pediatric Vaccines Market Outlook, By Allergy & respiratory drugs (2013-2022) ($MN)
Table 88 Europe Pediatric Vaccines Market Outlook, By CNS drugs (2013-2022) ($MN)
Table 89 Europe Pediatric Vaccines Market Outlook, By Vaccines type (2013-2022) ($MN)
Table 90 Europe Pediatric Vaccines Market Outlook, By Synthetic vaccines (2013-2022) ($MN)
Table 91 Europe Pediatric Vaccines Market Outlook, By Conjugate vaccines (2013-2022) ($MN)
Table 92 Europe Pediatric Vaccines Market Outlook, By Live attenuated vaccines (2013-2022) ($MN)
Table 93 Europe Pediatric Vaccines Market Outlook, By Dendritic cells vaccines (2013-2022) ($MN)
Table 94 Europe Pediatric Vaccines Market Outlook, By Toxoid vaccines (2013-2022) ($MN)
Table 95 Europe Pediatric Vaccines Market Outlook, By Recombinant vector vaccines (2013-2022) ($MN)
Table 96 Europe Pediatric Vaccines Market Outlook, By Subunit vaccines (2013-2022) ($MN)
Table 97 Europe Pediatric Vaccines Market Outlook, By Inactivated vaccines (2013-2022) ($MN)
Table 98 Asia Pacific Pediatric Vaccines Market Outlook, By Diseases type (2013-2022) ($MN)
Table 99 Asia Pacific Pediatric Vaccines Market Outlook, By Cancer and allergy (2013-2022) ($MN)
Table 100 Asia Pacific Pediatric Vaccines Market Outlook, By Infectious disease (2013-2022) ($MN)
Table 101 Asia Pacific Pediatric Vaccines Market Outlook, By Pneumococcal disease (2013-2022) ($MN)
Table 102 Asia Pacific Pediatric Vaccines Market Outlook, By Influenza (2013-2022) ($MN)
Table 103 Asia Pacific Pediatric Vaccines Market Outlook, By Diphtheria (2013-2022) ($MN)
Table 104 Asia Pacific Pediatric Vaccines Market Outlook, By Rotavirus (2013-2022) ($MN)
Table 105 Asia Pacific Pediatric Vaccines Market Outlook, By Tetanus (2013-2022) ($MN)
Table 106 Asia Pacific Pediatric Vaccines Market Outlook, By Haemophilus Influenzae type b (Hib) (2013-2022) ($MN)
Table 107 Asia Pacific Pediatric Vaccines Market Outlook, By Meningococcal (2013-2022) ($MN)
Table 108 Asia Pacific Pediatric Vaccines Market Outlook, By Hepatitis A (2013-2022) ($MN)
Table 109 Asia Pacific Pediatric Vaccines Market Outlook, By Hepatitis B (2013-2022) ($MN)
Table 110 Asia Pacific Pediatric Vaccines Market Outlook, By Rubella (2013-2022) ($MN)
Table 111 Asia Pacific Pediatric Vaccines Market Outlook, By Mumps (2013-2022) ($MN)
Table 112 Asia Pacific Pediatric Vaccines Market Outlook, By Measles (2013-2022) ($MN)
Table 113 Asia Pacific Pediatric Vaccines Market Outlook, By Pertussis (2013-2022) ($MN)
Table 114 Asia Pacific Pediatric Vaccines Market Outlook, By Varicella (chickenpox) (2013-2022) ($MN)
Table 115 Asia Pacific Pediatric Vaccines Market Outlook, By Polio (2013-2022) ($MN)
Table 116 Asia Pacific Pediatric Vaccines Market Outlook, By Product (2013-2022) ($MN)
Table 117 Asia Pacific Pediatric Vaccines Market Outlook, By Anti-infective drugs (2013-2022) ($MN)
Table 118 Asia Pacific Pediatric Vaccines Market Outlook, By Pediatric hormones (2013-2022) ($MN)
Table 119 Asia Pacific Pediatric Vaccines Market Outlook, By Allergy & respiratory drugs (2013-2022) ($MN)
Table 120 Asia Pacific Pediatric Vaccines Market Outlook, By CNS drugs (2013-2022) ($MN)
Table 121 Asia Pacific Pediatric Vaccines Market Outlook, By Vaccines type (2013-2022) ($MN)
Table 122 Asia Pacific Pediatric Vaccines Market Outlook, By Synthetic vaccines (2013-2022) ($MN)
Table 123 Asia Pacific Pediatric Vaccines Market Outlook, By Conjugate vaccines (2013-2022) ($MN)
Table 124 Asia Pacific Pediatric Vaccines Market Outlook, By Live attenuated vaccines (2013-2022) ($MN)
Table 125 Asia Pacific Pediatric Vaccines Market Outlook, By Dendritic cells vaccines (2013-2022) ($MN)
Table 126 Asia Pacific Pediatric Vaccines Market Outlook, By Toxoid vaccines (2013-2022) ($MN)
Table 127 Asia Pacific Pediatric Vaccines Market Outlook, By Recombinant vector vaccines (2013-2022) ($MN)
Table 128 Asia Pacific Pediatric Vaccines Market Outlook, By Subunit vaccines (2013-2022) ($MN)
Table 129 Asia Pacific Pediatric Vaccines Market Outlook, By Inactivated vaccines (2013-2022) ($MN)
Table 130 Rest of the World Pediatric Vaccines Market Outlook, By Diseases type (2013-2022) ($MN)
Table 131 Rest of the World Pediatric Vaccines Market Outlook, By Cancer and allergy (2013-2022) ($MN)
Table 132 Rest of the World Pediatric Vaccines Market Outlook, By Infectious disease (2013-2022) ($MN)
Table 133 Rest of the World Pediatric Vaccines Market Outlook, By Pneumococcal disease (2013-2022) ($MN)
Table 134 Rest of the World Pediatric Vaccines Market Outlook, By Influenza (2013-2022) ($MN)
Table 135 Rest of the World Pediatric Vaccines Market Outlook, By Diphtheria (2013-2022) ($MN)
Table 136 Rest of the World Pediatric Vaccines Market Outlook, By Rotavirus (2013-2022) ($MN)
Table 137 Rest of the World Pediatric Vaccines Market Outlook, By Tetanus (2013-2022) ($MN)
Table 138 Rest of the World Pediatric Vaccines Market Outlook, By Haemophilus Influenzae type b (Hib) (2013-2022) ($MN)
Table 139 Rest of the World Pediatric Vaccines Market Outlook, By Meningococcal (2013-2022) ($MN)
Table 140 Rest of the World Pediatric Vaccines Market Outlook, By Hepatitis A (2013-2022) ($MN)
Table 141 Rest of the World Pediatric Vaccines Market Outlook, By Hepatitis B (2013-2022) ($MN)
Table 142 Rest of the World Pediatric Vaccines Market Outlook, By Rubella (2013-2022) ($MN)
Table 143 Rest of the World Pediatric Vaccines Market Outlook, By Mumps (2013-2022) ($MN)
Table 144 Rest of the World Pediatric Vaccines Market Outlook, By Measles (2013-2022) ($MN)
Table 145 Rest of the World Pediatric Vaccines Market Outlook, By Pertussis (2013-2022) ($MN)
Table 146 Rest of the World Pediatric Vaccines Market Outlook, By Varicella (chickenpox) (2013-2022) ($MN)
Table 147 Rest of the World Pediatric Vaccines Market Outlook, By Polio (2013-2022) ($MN)
Table 148 Rest of the World Pediatric Vaccines Market Outlook, By Product (2013-2022) ($MN)
Table 149 Rest of the World Pediatric Vaccines Market Outlook, By Anti-infective drugs (2013-2022) ($MN)
Table 150 Rest of the World Pediatric Vaccines Market Outlook, By Pediatric hormones (2013-2022) ($MN)
Table 151 Rest of the World Pediatric Vaccines Market Outlook, By Allergy & respiratory drugs (2013-2022) ($MN)
Table 152 Rest of the World Pediatric Vaccines Market Outlook, By CNS drugs (2013-2022) ($MN)
Table 153 Rest of the World Pediatric Vaccines Market Outlook, By Vaccines type (2013-2022) ($MN)
Table 154 Rest of the World Pediatric Vaccines Market Outlook, By Synthetic vaccines (2013-2022) ($MN)
Table 155 Rest of the World Pediatric Vaccines Market Outlook, By Conjugate vaccines (2013-2022) ($MN)
Table 156 Rest of the World Pediatric Vaccines Market Outlook, By Live attenuated vaccines (2013-2022) ($MN)
Table 157 Rest of the World Pediatric Vaccines Market Outlook, By Dendritic cells vaccines (2013-2022) ($MN)
Table 158 Rest of the World Pediatric Vaccines Market Outlook, By Toxoid vaccines (2013-2022) ($MN)
Table 159 Rest of the World Pediatric Vaccines Market Outlook, By Recombinant vector vaccines (2013-2022) ($MN)
Table 160 Rest of the World Pediatric Vaccines Market Outlook, By Subunit vaccines (2013-2022) ($MN)
Table 161 Rest of the World Pediatric Vaccines Market Outlook, By Inactivated vaccines (2013-2022) ($MN)



【レポートのキーワード】

小児ワクチン、癌ワクチン、アレルギーワクチン、感染症ワクチン、治療ワクチン

★調査レポート[小児用ワクチンの世界市場] (コード:SMRC65156)販売に関する免責事項を必ずご確認ください。
★調査レポート[小児用ワクチンの世界市場]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆